ABVX
Abivax SA American Depositary Shares
NASDAQ: ABVX · HEALTHCARE · BIOTECHNOLOGY
$106.24
-3.30% today
Updated 2026-04-29
Market cap
$8.42B
P/E ratio
—
P/S ratio
1,843.30x
EPS (TTM)
$-5.66
Dividend yield
—
52W range
$6 – $149
Volume
1.0M
Abivax SA American Depositary Shares (ABVX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-3,743.00%
ROE
-135.60%
ROA
-39.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | $73945.00 | $-5.89M | -7,516.07% | -10,003.64% | -7,970.18% |
| 2014 | $14000.00 | $-5.08M | -23,321.43% | -36,100.00% | -36,285.71% |
| 2015 | $42000.00 | $-15.95M | -721.43% | -43,464.29% | -37,985.71% |
| 2016 | $127000.00 | $-14.31M | -11,431.50% | -14,359.06% | -11,266.14% |
| 2017 | $10000.00 | $-11.22M | -60.00% | -141,500.00% | -112,230.00% |
| 2018 | $18000.00 | $-15.82M | -277.78% | -106,155.56% | -87,905.56% |
| 2019 | $2000.00 | $-30.63M | -1,409,300.00% | -1,664,800.00% | -1,531,700.00% |
| 2020 | $63000.00 | $-37.55M | -53,601.59% | -60,330.16% | -59,604.76% |
| 2021 | $37000.00 | $-42.45M | -321.62% | -111,891.89% | -114,735.14% |
| 2022 | $4.58M | $-60.74M | 97.60% | -1,414.71% | -1,325.33% |
| 2023 | $4.62M | $-147.74M | 98.98% | -2,756.46% | -3,197.14% |
| 2024 | $10.79M | $-176.24M | 100.00% | -1,602.89% | -1,633.08% |
| 2025 | $0.00 | $-322.84M | — | — | — |